TipRanks
Can-Fite BioPharma Ltd. (IL:CANF)
TASE:CANF
Israel Market
Want to see IL:CANF full AI Analyst Report?

Can Fite Bio (CANF) Stock News & Sentiment

4 Followers
Can-Fite Buy Rating Reaffirmed as Clinical Momentum Builds and $8 Price Target Remains Unchanged
Premium
Ratings
Can-Fite Buy Rating Reaffirmed as Clinical Momentum Builds and $8 Price Target Remains Unchanged
2d ago
Buy Rating for Can-Fite BioPharma: Promising A3AR Agonists in Psoriasis and Liver Cancer with Strong Safety Profile
Premium
Ratings
Buy Rating for Can-Fite BioPharma: Promising A3AR Agonists in Psoriasis and Liver Cancer with Strong Safety Profile
11M ago
Can-Fite’s Namodenoson Shows Promise in Treating Liver Cirrhosis
Premium
Company Announcements
Can-Fite’s Namodenoson Shows Promise in Treating Liver Cirrhosis
2y ago

News Score - Last 7 Days

Neutral
IL:CANF
Sector Average
Media Buzz
This Week1 articles
Weekly Average0.5 articles
News Sentiment
This Week100%
Sector Average89%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is IL:CANF’s Media Buzz Sentiment?
1 articles about IL:CANF were published this week. In an average week, 0.5 articles are published.
    What is IL:CANF’s weekly average amount of articles?
    In an average week, 0.5 articles about IL:CANF are published.
      What is IL:CANF’s News Sentiment?
      100% of articles about IL:CANF were positive this week, compared to its sector average of 89%.
        General Stocks that are Trending in the News
        RPDRapid7
        TERATera Yatirim Menkul Degerler AS
        R2PD34Rapid7 Inc Shs Unsponsored Brazilian Depositary Receipt Repr 0.083333 Sh
        T2TD34Trade Desk, Inc. Shs A Unsponsored Brazilian Depositary Receipt Repr 0.01 Sh A
        T1AM34Atlassian Corp Shs A Unsponsored Brazilian Depository Receipt Repr 0.05 Sh A
        Showing the stocks with the most bullish news sentiment over the past week